Interactive Investor
>>

Sensorion SA (EURONEXT:ALSEN) Share Price

ALSEN

Sensorion SA

European company

Right Arrow 1

Healthcare

Right Arrow 2

Biotechnology

 / 

- / -
-
- / -
-
-
-

Bid

-

Ask

-

Last Traded

-

Chg

-

-

XPAR

-

Updated: -

Research

News & analysis

Loading...

Times are shown in GMT+2, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.

This stock can be held in:

 / 

- / -
-
- / -
-
-
-

Company Profile

Sensorion SA is a France-based clinical-stage biotech company dedicated to the development of innovative therapies to restore, treat and prevent hearing loss. The company's product is in Phase 2 clinical development, SENS-401 (Arazasetron) in Sudden Sensorineural Hearing Loss (SSNHL). SENS-401 is being developed to treat cochlear pathologies.Sensorion SA develops therapies dedicated to the treatment of vestibular and cochlear pathologies. Its product pipeline includes SENS-111, which is a treatment against acute dizziness.

EURONEXT:ALSEN

FR0012596468

EUR

Loading...

Loading Comparison

Latest ALSEN News